Sue Siegel

KFF is the independent source for health policy research, polling, and news.

Together, The Engine Accelerator and Engine Ventures are bridging the gap between discovery and commercialization for breakthrough inventions and accelerating the pathway for Tough Tech founders and companies. Our mission is to address the planet’s most challenging problems and create a positive impact on society and the environment by building Tough Tech.

The Engine supports Tough Tech teams who are working to solve the world’s toughest challenges through the convergence of science and engineering. We curate comprehensive programs, provide access to specialized infrastructure including labs, equipment, tools, and workspace as well as convene the ecosystem necessary to build transformative technologies from idea to impact.

Venture capitalists are committed to funding America’s most innovative entrepreneurs, working closely with them to transform breakthrough ideas into emerging growth companies that drive U.S. job creation and economic growth. As the voice of the U.S. venture capital community, the National Venture Capital Association empowers its members and the entrepreneurs they fund by advocating for policies that encourage innovation and reward long-term investment. The NVCA also serves as the definitive resource for venture capital data and unites its members through a full range of professional services.

Corventis, Inc. is a pioneer in wireless cardiovascular solutions. The company’s patient- and physician-friendly technology is designed to enable early detection of clinical events for timely diagnosis and treatment by clinicians…without impacting patient lifestyle. Corventis is funded by prominent venture capital firms, Kleiner, Perkins, Caufield & Byers, Mohr Davidow Ventures, PTV Ventures and DAG Ventures.

Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Through HFX, Nevro brings together enduring technologies, optimized therapies, and individualized patient support, all built on a foundation of proof that results in a comprehensive solution to relieve the burden of pain for more patients. HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz.

KFF is the independent source for health policy research, polling, and news.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, youll make an impact on the market leader thats moving an industry forward. Want to find out whats next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com

Together, The Engine Accelerator and Engine Ventures are bridging the gap between discovery and commercialization for breakthrough inventions and accelerating the pathway for Tough Tech founders and companies. Our mission is to address the planet’s most challenging problems and create a positive impact on society and the environment by building Tough Tech.